Ranitidine ip 150 mg

Chemically it is N[2-[[[5-[ dimethylamino methyl]furanyl]methyl]thio]ethyl]-N'-methylnitro-1,1-ethenediamine, HCl.

Ranitidine belongs to the class of medications called H2-antagonists. It works by reducing the amount of acid secreted by the stomach in order to reduce ulcer and heartburn pain or to assist in healing of ulcers. Ranitidine is used to treat and prevent stomach ulcers caused by non-steroidal anti-inflammatory drugs NSAIDs ; to prevent bleeding caused by stress ulcers for very ill people; to prevent a second episode of bleeding in the digestive tract caused by bleeding ulcers; and to prevent inhalation of stomach acid during surgery, for people who are considered at risk of this complication. It is used to treat stomach and duodenal intestinal ulcers, and prevent them from recurring. Any specific brand name of this medication may not be available in all of the forms or approved for all of the conditions discussed here.

Ranitidine ip 150 mg

Ranitidine , sold under the brand name Zantac among others, is a medication used to decrease stomach acid production. In September , the probable carcinogen N -nitrosodimethylamine NDMA was discovered in ranitidine products from a number of manufacturers, resulting in recalls. In April , ranitidine was withdrawn from the United States market and suspended in the European Union and Australia due to these concerns. In , these concerns were confirmed in a nationwide [ which? Common side effects include headaches and pain or burning if given by injection. Ranitidine was discovered in England in , and came into commercial use in It has been withdrawn at regulator request from most markets, including the United States; [12] it has been discontinued globally, according to the NHS. Ranitidine has been discontinued globally, according to the NHS , [30] and is contraindicated due to excess cancer risk and the ready availability of H2 antagonist and PPI alternatives. Rare reports have been made of ranitidine causing malaise , dizziness , somnolence , insomnia , and vertigo. In severely ill, elderly patients, cases of reversible mental confusion, agitation, depression, and hallucinations have been reported. Arrhythmias such as tachycardia , bradycardia , atrioventricular block , and premature ventricular beats have also been reported. All drugs in the H 2 receptor blocker class of medicines have the potential to cause vitamin B 12 deficiency, secondary to a reduction in food-bound vitamin B 12 absorption. Patients who take these agents develop higher levels of immunoglobulin E against food, whether they had prior antibodies or not.

Geriatric Use: Of the total number of subjects enrolled in US and foreign controlled clinical trials of oral formulations of Ranitidine Tablets, for which there were subgroup analyses, 4, were 65 and over, while were 75 and over. Maintenance of Healing of Erosive Esophagitis: In 2 multicenter, ranitidine ip 150 mg, randomized, placebo-controlled, week trials conducted in patients whose erosive esophagitis had been previously healed, ranitidine ip 150 mg, Ranitidine Tablets USP, mg twice daily was significantly more effective than placebo in maintaining healing of erosive esophagitis.

If you are a consumer or patient please visit this version. Chemically it is N[2-[[[5-[ dimethylamino methyl]furanyl]methyl]thio]ethyl]-N'-methylnitro-1,1-ethenediamine, HCl. It has the following structure:. Ranitidine HCl is a white to pale yellow, granular substance that is soluble in water. It has a slightly bitter taste and sulfur like odor.

If you are a consumer or patient please visit this version. Allergy alert: Do not use if you are allergic to ranitidine or any other acid reducers. If pregnant or breastfeeding , ask a health professional before use. In case of overdose, get medical help or contact a Poison Control Center right away. Call Monday to Friday a.

Ranitidine ip 150 mg

Last Updated: November 7, References. This article was medically reviewed by Janice Litza, MD. With over 25 years of educational and professional experience, she has extensive experience providing full-spectrum Family Medicine, including obstetrics, newborn care, and hospital medicine. There are 8 references cited in this article, which can be found at the bottom of the page. This article has been viewed 14, times. Ranitidine is a common over-the-counter medication that works by reducing the amount of acid produced by the stomach.

Fish coloring sheet

Children between the ages of 8 years and 16 years of age, should only use this medication under the supervision of a doctor. There are, however, no adequate and well-controlled studies in pregnant women. We anticipate reposting the images once we are able identify and filter out images that do not match the information provided in the drug labels. Below is the list of medicines, which have the same composition, strength and form as Ranitidine MG Tablet , and hence can be used as its substitute. It is advised to replace one or both of these medicines with alternates that do not interact. Chronicles of Drug Discovery. Due to the narrow therapeutic index, close monitoring of increased or decreased prothrombin time is recommended during concurrent treatment with ranitidine. However, occasional cases of impotence and loss of libido have been reported in male patients receiving Ranitidine Tablets, but the incidence did not differ from that in the general population. Maintenance of healing of erosive esophagitis. Ans : This medication starts working as fast as 15 minutes from when it is given. Intrinsic Factor: Oral Ranitidine Tablets has no significant effect on pentagastrin-stimulated intrinsic factor secretion. Does this affect kidney function? Retrieved 24 September

If you are a consumer or patient please visit this version. Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers.

Archived from the original on 28 December Please help improve this section if you can. Headache, sometimes severe, seems to be related to administration of Ranitidine Tablets. Inactive Ingredients. Chronicles of Drug Discovery. No information regarding dose adjustment is available in hepatic patients. Time After Dose, hours. In September , the probable carcinogen N -nitrosodimethylamine NDMA was discovered in ranitidine products from a number of manufacturers, resulting in recalls; in April , it was withdrawn from the United States market and suspended in Europe and Australia. Thus, gastric acid secretion process is inhibited. Replace cap securely after each opening.